PD-1/PD-L1 inhibitor-induced hyponatremia: a real-world pharmacovigilance analysis using FAERS database
This pharmacovigilance analysis reveals the association between PD-1/PD-L1 inhibitors and hyponatremia, offering valuable insights to refine treatment strategies and improve risk management for this AE.
Authors
- Yan Dai (ORCID: https://orcid.org/0000-0002-5347-5136)
- Huanhuan He (ORCID: https://orcid.org/0000-0002-5903-0840)
- Bingyao Liu (ORCID: https://orcid.org/0000-0002-7369-7019)
- Jiming Lv (ORCID: https://orcid.org/0000-0001-5269-0312)
- Liuxuan Yang
- Meiling Zhou (ORCID: https://orcid.org/0000-0002-0559-2450)
- Xiaoqun Ren
- Qian Ding (ORCID: https://orcid.org/0000-0002-5961-5945)
- Kun Chen (ORCID: https://orcid.org/0000-0002-3955-3791)
- Ke Wang (ORCID: https://orcid.org/0000-0003-0404-9779)
- Chao Tao (ORCID: https://orcid.org/0009-0003-8034-7492)
Institutions
- Sichuan University (CN)
- Southwest Medical University (CN)
- Affiliated Hospital of Southwest Medical University (CN)
- West China Hospital of Sichuan University (CN)
- Mianyang Third People's Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-06-16
- DOI
- https://doi.org/10.3389/fimmu.2025.1561942
- Citations
- 2
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 2.61
Funders
- National Natural Science Foundation of China
- Southwest Medical University